BBOT

BridgeBio Oncology Therapeutics, Inc. Common Stock

BBOT • NASDAQ

BridgeBio Oncology Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Eli Wallace, with a market cap of $811.9M.

CEOEli Wallace
Market Cap$811.9M

Next Earnings

Upcoming earnings announcement for BridgeBio Oncology Therapeutics, Inc. Common Stock

Date
Thursday, February 26, 2026 (in 2 weeks)
Timing
Before Market Open (8:21 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.59

Earnings History

Past 1 earnings report for BridgeBio Oncology Therapeutics, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 12, 2025Q3 2025
-$1.03Est: -$0.37
-178.4%
-
——

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.